Moreover, S100B levels in cerebrospinal fluid, together with other AD biomarkers, such as Aβ and phosphorylated tau, have recently been shown to have an inverse correlation with gray matter volumes and glucose metabolism in key AD-related regions [164, 165]. This evidence concerns the gene MAPT and Alzheimer disease.